Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Bob A. Rappaport"'
Autor:
Robert R. Edwards, Robert H. Dworkin, Dennis C. Turk, Martin S. Angst, Raymond Dionne, Roy Freeman, Per Hansson, Simon Haroutounian, Lars Arendt-Nielsen, Nadine Attal, Ralf Baron, Joanna Brell, Shay Bujanover, Laurie B. Burke, Daniel Carr, Amy S. Chappell, Penney Cowan, Mila Etropolski, Roger B. Fillingim, Jennifer S. Gewandter, Nathaniel P. Katz, Ernest A. Kopecky, John D. Markman, George Nomikos, Linda Porter, Bob A. Rappaport, Andrew S.C. Rice, Joseph M. Scavone, Joachim Scholz, Lee S. Simon, Shannon M. Smith, Jeffrey Tobias, Tina Tockarshewsky, Christine Veasley, Mark Versavel, Ajay D. Wasan, Warren Wen, David Yarnitsky
Publikováno v:
PAIN Reports, Vol 6, Iss 1, p e899 (2021)
Abstract. There is tremendous interpatient variability in the response to analgesic therapy (even for efficacious treatments), which can be the source of great frustration in clinical practice. This has led to calls for “precision medicine” or pe
Externí odkaz:
https://doaj.org/article/daf3aa186f274684ac1ec5b80f599fe5
Autor:
Jennifer S. Gewandter, Robert H. Dworkin, Dennis C. Turk, John T. Farrar, Roger B. Fillingim, Ian Gilron, John D. Markman, Anne Louise Oaklander, Michael J. Polydefkis, Srinivasa N. Raja, James P. Robinson, Clifford J. Woolf, Dan Ziegler, Michael A. Ashburn, Laurie B. Burke, Penney Cowan, Steven Z. George, Veeraindar Goli, Ole X. Graff, Smriti Iyengar, Gary W. Jay, Joel Katz, Henrik Kehlet, Rachel A. Kitt, Ernest A. Kopecky, Richard Malamut, Michael P. McDermott, Pamela Palmer, Bob A. Rappaport, Christine Rauschkolb, Ilona Steigerwald, Jeffrey Tobias, Gary A. Walco
Publikováno v:
PAIN Reports, Vol 6, Iss 1, p e895 (2021)
Abstract. Although certain risk factors can identify individuals who are most likely to develop chronic pain, few interventions to prevent chronic pain have been identified. To facilitate the identification of preventive interventions, an IMMPACT mee
Externí odkaz:
https://doaj.org/article/0106332128fd4ca3815612d7abe61e83
Autor:
Joachim Scholz, Roger B. Fillingim, David Yarnitsky, Tina Tockarshewsky, Shannon M. Smith, Dennis C. Turk, Shay Bujanover, Daniel B. Carr, Nadine Attal, Joanna M. Brell, Jeffrey Tobias, Nathaniel P. Katz, Penney Cowan, Joseph M. Scavone, Mila Etropolski, Martin S. Angst, Linda Porter, Jennifer S. Gewandter, Simon Haroutounian, Warren Wen, Robert H. Dworkin, Raymond A. Dionne, Mark Versavel, John D. Markman, Ajay D. Wasan, Christine Veasley, Lee S. Simon, Andrew S.C. Rice, Per Hansson, Robert R. Edwards, Ernest A. Kopecky, Lars Arendt-Nielsen, Amy S. Chappell, R. Baron, Bob A. Rappaport, George G. Nomikos, Laurie B. Burke, Roy Freeman
Publikováno v:
PAIN Reports, Vol 6, Iss 1, p e899 (2021)
Edwards, R R, Dworkin, R H, Turk, D C, Angst, M S, Dionne, R, Freeman, R, Hansson, P, Haroutounian, S, Arendt-Nielsen, L, Attal, N, Baron, R, Brell, J, Bujanover, S, Burke, L B, Carr, D, Chappell, A S, Cowan, P, Etropolski, M, Fillingim, R B, Gewandter, J S, Katz, N P, Kopecky, E A, Markman, J D, Nomikos, G, Porter, L, Rappaport, B A, Rice, A S C, Scavone, J M, Scholz, J, Simon, L S, Smith, S M, Tobias, J, Tockarshewsky, T, Veasley, C, Versavel, M, Wasan, A D, Wen, W & Yarnitsky, D 2016, ' Patient phenotyping in clinical trials of chronic pain treatments : IMMPACT recommendations ', Pain, vol. 157, no. 9, pp. 1851-1871 . https://doi.org/10.1097/j.pain.0000000000000602
Edwards, R R, Dworkin, R H, Turk, D C, Angst, M S, Dionne, R, Freeman, R, Hansson, P, Haroutounian, S, Arendt-Nielsen, L, Attal, N, Baron, R, Brell, J, Bujanover, S, Burke, L B, Carr, D, Chappell, A S, Cowan, P, Etropolski, M, Fillingim, R B, Gewandter, J S, Katz, N P, Kopecky, E A, Markman, J D, Nomikos, G, Porter, L, Rappaport, B A, Rice, A S C, Scavone, J M, Scholz, J, Simon, L S, Smith, S M, Tobias, J, Tockarshewsky, T, Veasley, C, Versavel, M, Wasan, A D, Wen, W & Yarnitsky, D 2021, ' Patient phenotyping in clinical trials of chronic pain treatments : IMMPACT recommendations ', Pain Reports, vol. 6, no. 1, e896 . https://doi.org/10.1097/pr9.0000000000000896
Edwards, R R, Dworkin, R H, Turk, D C, Angst, M S, Dionne, R, Freeman, R, Hansson, P, Haroutounian, S, Arendt-Nielsen, L, Attal, N, Baron, R, Brell, J, Bujanover, S, Burke, L B, Carr, D, Chappell, A S, Cowan, P, Etropolski, M, Fillingim, R B, Gewandter, J S, Katz, N P, Kopecky, E A, Markman, J D, Nomikos, G, Porter, L, Rappaport, B A, Rice, A S C, Scavone, J M, Scholz, J, Simon, L S, Smith, S M, Tobias, J, Tockarshewsky, T, Veasley, C, Versavel, M, Wasan, A D, Wen, W & Yarnitsky, D 2016, ' Patient phenotyping in clinical trials of chronic pain treatments : IMMPACT recommendations ', Pain, vol. 157, no. 9, pp. 1851-1871 . https://doi.org/10.1097/j.pain.0000000000000602
Edwards, R R, Dworkin, R H, Turk, D C, Angst, M S, Dionne, R, Freeman, R, Hansson, P, Haroutounian, S, Arendt-Nielsen, L, Attal, N, Baron, R, Brell, J, Bujanover, S, Burke, L B, Carr, D, Chappell, A S, Cowan, P, Etropolski, M, Fillingim, R B, Gewandter, J S, Katz, N P, Kopecky, E A, Markman, J D, Nomikos, G, Porter, L, Rappaport, B A, Rice, A S C, Scavone, J M, Scholz, J, Simon, L S, Smith, S M, Tobias, J, Tockarshewsky, T, Veasley, C, Versavel, M, Wasan, A D, Wen, W & Yarnitsky, D 2021, ' Patient phenotyping in clinical trials of chronic pain treatments : IMMPACT recommendations ', Pain Reports, vol. 6, no. 1, e896 . https://doi.org/10.1097/pr9.0000000000000896
There is tremendous interpatient variability in the response to analgesic therapy (even for efficacious treatments), which can be the source of great frustration in clinical practice. This has led to calls for “precision medicine” or personalized
Autor:
Smriti Iyengar, Pamela Palmer, Michael P. McDermott, Gary W. Jay, Srinivasa N. Raja, Rachel A. Kitt, Veeraindar Goli, Jeffrey Tobias, Richard Malamut, Ian Gilron, Laurie B. Burke, Christine Rauschkolb, Gary A. Walco, Steven Z. George, John T. Farrar, Ole Graff, Dennis C. Turk, Henrik Kehlet, Penney Cowan, Roger B. Fillingim, Bob A. Rappaport, Ernest A. Kopecky, Jennifer S. Gewandter, Clifford J. Woolf, Michael Polydefkis, Anne Louise Oaklander, Robert H. Dworkin, James P. Robinson, Joel Katz, Dan Ziegler, John D. Markman, Ilona Steigerwald, Michael A. Ashburn
Publikováno v:
PAIN Reports, Vol 6, Iss 1, p e895 (2021)
Pain Reports
Pain Reports
Supplemental Digital Content is Available in the Text.
Although certain risk factors can identify individuals who are most likely to develop chronic pain, few interventions to prevent chronic pain have been identified. To facilitate the identifi
Although certain risk factors can identify individuals who are most likely to develop chronic pain, few interventions to prevent chronic pain have been identified. To facilitate the identifi
Autor:
Bob A. Rappaport, John W. Berkenbosch, Raymond A. Dionne, David Gozal, Rebecca S. Twersky, Joseph P. Cravero, Mark R. Williams, Randall M. Clark, David Grayzel, Dennis C. Turk, Daniel I. Sessler, Michael R. Irwin, Pratik P. Pandharipande, Franklin Dexter, Keira P. Mason, Jerrold Lerman, Richard R. Riker, Robert H. Dworkin, John J. Vargo, Robert E. O'Connor, Denham S. Ward, Isabelle Constant, Douglas W. Carlson, Jenifer R. Lightdale, Joseph R. Tobin, James R. Miner
Publikováno v:
Anesthesia & Analgesia. 124:821-830
The Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research, established by the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks public-private partnership with
Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy
Autor:
Bryce B. Reeve, Shannon M. Smith, Justin C. McArthur, A. Gordon Smith, Tony D. Gover, James W. Russell, Jennifer S. Gewandter, Roy Freeman, Bob A. Rappaport, Dennis C. Turk, Aaron I. Vinik, Robert H. Dworkin, Guido Cavaletti, David N. Herrmann, Laurie B. Burke, Michael P. McDermott, Christopher H. Gibbons
Publikováno v:
Muscle & Nerve. 55:366-372
Introduction: No treatments for axonal peripheral neuropathy are approved by the United States Food and Drug Administration (FDA). Although patient- and clinician-reported outcomes are central to evaluating neuropathy symptoms, they can be difficult
Autor:
Andrew McKeown, Nathaniel P. Katz, Kendrick Lee, Bob A. Rappaport, Paul Coplan, Robert H. Dworkin, Michael P. McDermott, Michael C. Rowbotham, Shannon M. Smith, Zachary Pressman, Srinivasa N. Raja, Dennis C. Turk, Mark R. Williams, Ian Gilron, Matthew Hunsinger
Publikováno v:
The Journal of Pain. 17:1137-1149
Thorough assessment and reporting of adverse events (AEs) facilitates a detailed understanding of a treatment's risk–benefit profile. Although the Consolidated Standards of Reporting Trials (CONSORT) 2004 statement provides recommendations regardin
Autor:
Stephen A. Cooper, Nathaniel P. Katz, Penney Cowan, Märta Segerdahl, Jane C. Ballantyne, Christine Rauschkolb, Dennis C. Turk, Paul J. Desjardins, Eugene J. Carragee, Henrik Kehlet, Raymond A. Dionne, Eija Kalso, Mark S. Wallace, Joseph W. Stauffer, Mike A. Royal, Christopher L. Wu, Smriti Iyengar, Debra B. Gordon, Gary W. Jay, John T. Farrar, Laurie B. Burke, Srinivasa N. Raja, Richard E. White, Scott Croll, Bob A. Rappaport, Robert H. Dworkin, Geertrui F. Vanhove, Michael P. McDermott, Ian Gilron, Knox H. Todd, Christine R. West, Robert D. Kerns
Publikováno v:
Pain. 157:288-301
This article summarizes the results of a meeting convened by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) on key considerations and best practices governing the design of acute pain clinical trials. We disc
Autor:
Robert A. Gross, Andrew S.C. Rice, Jordan D. Dworkin, Bob A. Rappaport, Jennifer S. Gewandter, Matthew Hunsinger, Andrew McKeown, Allison H. Lin, Dennis C. Turk, Shannon M. Smith, Robert H. Dworkin, Mark R. Williams, Michael P. McDermott, Michael C. Rowbotham
Publikováno v:
The Journal of Pain. 16:3-10
Peer-reviewed publications of randomized clinical trials (RCTs) are the primary means of disseminating research findings. "Spin" in RCT publications is misrepresentation of statistically nonsignificant research findings to suggest treatment benefit.
Autor:
Tuhina Neogi, Joanne M. Jordan, Sarah Peirce-Sandner, Bob A. Rappaport, Lee S. Simon, Hua He, Nathaniel P. Katz, Dennis C. Turk, Marc C. Hochberg, Allison H. Lin, Robert H. Dworkin, Michael P. McDermott, Vibeke Strand
Publikováno v:
Arthritis & Rheumatology. 66:3327-3336
Objective To identify patient, study, and site factors associated with assay sensitivity in clinical trials of pharmacologic treatments for osteoarthritis (OA) pain. Methods We examined associations between study characteristics and the standardized